세계의 세균성 질염 시장 보고서(2025년)

Bacterial Vaginosis Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세균성 질염 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 예측 기간의 성장은 건강상태의 만연 증가, 갱년기에 대한 의식의 고조에 기인하고 있습니다.

성병(STI)의 이환율이 증가하면 세균성 질염 시장의 성장을 가속할 것으로 예측됩니다. 방어적인 성행위, 여러 파트너, 인식 부족, 항생제 내성 등 여러 요인이 STI의 만연을 증가시키고 있습니다. 예를 들어, 2024년 3월 스웨덴에 본사를 둔 정부 기관인 유럽 질병 예방 관리 센터(ECDC)는 2022년 STI 환자수가 전년에 비해 대폭 증가하여 임병이 48%, 매독이 34%, 클라미디아가 16% 증가했다고 보고했으며, 그 결과 STI 이환율 증가가 세균성 질염 시장 확대에 박차를 가했습니다.

세균성 질염 시장의 주요 기업은 진단 및 치료를 가속화하기 위해 다중화 중합효소 연쇄반응(PCR) 검사와 같은 혁신적인 솔루션을 개발하고 있습니다. 다중 PCR 검사는 단일 실험에서 여러 표적 DNA 또는 RNA 서열의 동시 증폭 및 검출을 가능하게 합니다. 예를 들어 2022년 11월 미국의 생명공학 연구회사인 세파이드는 Xpert Xpress Multiplex Vaginal Panel(MVP)을 출시했습니다. 이 검사는 60분 이내에 신속한 결과를 가져오고, 한 샘플에서 세 가지 질 감염 박테리아 질염(BV), 외음질 칸디다증(VVC), 트리코모나스증(TV)을 검출합니다. 임상의가 채취한 면봉과 스스로 채취한 면봉 모두에 대응하도록 설계된 이 검사는 진단 정확도와 치료 성적을 향상시키는 자동 실시간 PCR 기술을 이용하고 있습니다. 다용도가 높기 때문에 다양한 임상 현장에서 사용할 수 있어 질 감염의 효율적이고 정확한 검출을 보장합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 세균성 질염 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 세균성 질염 시장 : 성장률 분석
• 세계의 세균성 질염 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 세균성 질염 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 세균성 질염 전체 시장(TAM)

제6장 시장 세분화

• 세계의 세균성 질염 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 현장 검사
• 실험실 검사
• 기타 유형
• 세계의 세균성 질염 시장 : 제품별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 15세 미만
• 15-45세
• 44세 이상
• 임산부
• 기타 제품
• 세계의 세균성 질염 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 항생제
• 기타 용도
• 세계의 세균성 질염 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 홈케어
• 전문 클리닉
• 기타 최종 사용자
• 세계의 세균성 질염 시장 : 현장 검사 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 신속 진단 검사
• 현미경 기반 검사
• 면역 검사
• 세계의 세균성 질염 시장 : 실험실 검사 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 그람 염색
• 중합효소 연쇄반응(PCR)
• DNA 프로브 검사
• 배양 기반 검사
• 세계의 세균성 질염 시장 : 기타 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 홈 테스트 키트
• 효소결합 면역 흡착 분석법(ELISA)

제7장 지역별/국가별 분석

• 세계의 세균성 질염 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 세균성 질염 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 세균성 질염 시장 : 경쟁 구도
• 세균성 질염 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck KGaA 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
  • Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Thermo Fisher Scientific
• Becton Dickinson
• Viatris Inc.
• Otsuka Pharmaceutical
• LabCorp
• Quest Diagnostics
• Organon & Co.
• UT Southwestern Medical Center
• Hologic Inc.
• bioMerieux SA
• Shionogi & Company Limited
• Melinta Therapeutics Inc.
• Evofem Biosciences
• Gedea Biotech
• Fleurstat

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 세균성 질염 시장(2029년) : 새로운 기회를 제공하는 국가
• 세균성 질염 시장(2029년) : 새로운 기회를 제공하는 부문
• 세균성 질염 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Bacterial vaginosis (BV) is a prevalent vaginal infection resulting from an imbalance in naturally occurring bacteria. This imbalance leads to a reduction in lactobacilli and an overgrowth of anaerobic bacteria. Common symptoms include a fishy odor, thin grayish-white discharge, and vaginal discomfort, though some cases may be asymptomatic.

The primary categories of bacterial vaginosis include point-of-care testing, laboratory testing, and others. Point-of-care testing (POCT) involves medical diagnostic tests conducted at or near the patient's location, delivering rapid results for immediate clinical decision-making. Various product categories include those designed for individuals under 15 years, those aged 15-45 years, and others. Applications consist of antibiotics and alternative treatments, utilized by different end users such as hospitals, home care settings, specialty clinics, and others.

The bacterial vaginosis market research report is one of a series of new reports from The Business Research Company that provides bacterial vaginosis market statistics, including the bacterial vaginosis industry's global market size, regional shares, competitors with a bacterial vaginosis market share, detailed bacterial vaginosis market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial vaginosis industry. This bacterial vaginosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bacterial vaginosis market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.32 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to the increased adoption of point-of-care diagnostics, the expansion of e-commerce, a rise in risky sexual behaviors, the growth of STI vaccination, and improved healthcare access.

The bacterial vaginosis market size is expected to see strong growth in the next few years. It will grow to $4.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to the increasing prevalence of bacterial vaginosis, rising demand for functional foods, a growing incidence of STIs, the increasing prevalence of women's health conditions, and greater awareness of menopause. Key trends expected during this period include the integration of artificial intelligence (AI) in diagnostics, the adoption of probiotics, advancements in home-based STI testing, and the use of sustainable materials in women's health devices.

The rising incidence of sexually transmitted infections (STIs) is expected to drive the growth of the bacterial vaginosis market. STIs are infections primarily transmitted through sexual contact and can be caused by bacteria, viruses, or parasites. Several factors contribute to the increasing prevalence of STIs, including unprotected sex, multiple partners, lack of awareness, and antibiotic resistance. Bacterial vaginosis increases vulnerability to STIs by disrupting the vaginal bacterial balance, making it easier for infections such as HIV and chlamydia to take hold. For example, in March 2024, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported a significant rise in STI cases in 2022 compared to the previous year, with gonorrhea increasing by 48%, syphilis by 34%, and chlamydia by 16%. As a result, the growing incidence of STIs is fueling the expansion of the bacterial vaginosis market.

Leading companies in the bacterial vaginosis market are developing innovative solutions such as multiplexed polymerase chain reaction (PCR) tests to accelerate diagnosis and treatment. A multiplexed PCR test enables the simultaneous amplification and detection of multiple target DNA or RNA sequences within a single experiment. For instance, in November 2022, Cepheid, a US-based biotechnology research company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP). This test delivers rapid results in under 60 minutes and detects three vaginal infections bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) from a single sample. Designed for both clinician-collected and self-collected swabs, the test utilizes automated real-time PCR technology to improve diagnostic accuracy and treatment outcomes. Its versatility allows for use in various clinical settings, ensuring efficient and precise detection of vaginal infections.

In July 2024, Evofem Biosciences, a US-based biopharmaceutical company, acquired the US commercial women's health specialty business from Lupin Limited for $84 million. This acquisition is intended to expand Evofem Biosciences' portfolio in women's health by adding an FDA-approved treatment for bacterial vaginosis and trichomoniasis. Lupin Limited, an India-based pharmaceutical company, specializes in the development and distribution of a wide range of healthcare products, including women's health specialty treatments.

Major players in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMerieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, and Medical Diagnostic Laboratories.

North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in bacterial vaginosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bacterial vaginosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bacterial vaginosis market includes revenues earned by entities by providing services such as wet mount microscopy, pH testing, and dietary recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The bacterial vaginosis (BV) market consists of sales of oral and topical antibiotics, probiotics, pH balancers, gels, and creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bacterial Vaginosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bacterial vaginosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bacterial vaginosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bacterial vaginosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Point-Of-Care Testing; Laboratory Testing; Other Types
• 2) By Product: Below 15 Years; Between 15-45; Other Products
• 3) By Application: Antibiotics; Other Applications
• 4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Point-Of-Care Testing: Rapid Diagnostic Tests; Microscopy-based Tests; Immunoassays
• 2) By Laboratory Testing: Gram Staining; Polymerase Chain Reaction (PCR); DNA Probe Tests; Culture-based Testing
• 3) By Other Types: Home Testing Kits; Enzyme-linked Immunosorbent Assay (ELISA)
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Merck KGaA; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bacterial Vaginosis Market Characteristics

3. Bacterial Vaginosis Market Trends And Strategies

4. Bacterial Vaginosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bacterial Vaginosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bacterial Vaginosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bacterial Vaginosis Market Growth Rate Analysis
• 5.4. Global Bacterial Vaginosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bacterial Vaginosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bacterial Vaginosis Total Addressable Market (TAM)

6. Bacterial Vaginosis Market Segmentation

• 6.1. Global Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point-Of-Care Testing
• Laboratory Testing
• Other Types
• 6.2. Global Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Below 15 Years
• Between 15-45
• Above 44 Years
• Pregnant Women
• Other Products
• 6.3. Global Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Other Applications
• 6.4. Global Bacterial Vaginosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Bacterial Vaginosis Market, Sub-Segmentation Of Point-Of-Care Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Diagnostic Tests
• Microscopy-based Tests
• Immunoassays
• 6.6. Global Bacterial Vaginosis Market, Sub-Segmentation Of Laboratory Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gram Staining
• Polymerase Chain Reaction (PCR)
• DNA Probe Tests
• Culture-based Testing
• 6.7. Global Bacterial Vaginosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Home Testing Kits
• Enzyme-linked Immunosorbent Assay (ELISA)

7. Bacterial Vaginosis Market Regional And Country Analysis

• 7.1. Global Bacterial Vaginosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bacterial Vaginosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bacterial Vaginosis Market

• 8.1. Asia-Pacific Bacterial Vaginosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bacterial Vaginosis Market

• 9.1. China Bacterial Vaginosis Market Overview
• 9.2. China Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bacterial Vaginosis Market

• 10.1. India Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bacterial Vaginosis Market

• 11.1. Japan Bacterial Vaginosis Market Overview
• 11.2. Japan Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bacterial Vaginosis Market

• 12.1. Australia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bacterial Vaginosis Market

• 13.1. Indonesia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bacterial Vaginosis Market

• 14.1. South Korea Bacterial Vaginosis Market Overview
• 14.2. South Korea Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bacterial Vaginosis Market

• 15.1. Western Europe Bacterial Vaginosis Market Overview
• 15.2. Western Europe Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bacterial Vaginosis Market

• 16.1. UK Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bacterial Vaginosis Market

• 17.1. Germany Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bacterial Vaginosis Market

• 18.1. France Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bacterial Vaginosis Market

• 19.1. Italy Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bacterial Vaginosis Market

• 20.1. Spain Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bacterial Vaginosis Market

• 21.1. Eastern Europe Bacterial Vaginosis Market Overview
• 21.2. Eastern Europe Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bacterial Vaginosis Market

• 22.1. Russia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bacterial Vaginosis Market

• 23.1. North America Bacterial Vaginosis Market Overview
• 23.2. North America Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bacterial Vaginosis Market

• 24.1. USA Bacterial Vaginosis Market Overview
• 24.2. USA Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bacterial Vaginosis Market

• 25.1. Canada Bacterial Vaginosis Market Overview
• 25.2. Canada Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bacterial Vaginosis Market

• 26.1. South America Bacterial Vaginosis Market Overview
• 26.2. South America Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bacterial Vaginosis Market

• 27.1. Brazil Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bacterial Vaginosis Market

• 28.1. Middle East Bacterial Vaginosis Market Overview
• 28.2. Middle East Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bacterial Vaginosis Market

• 29.1. Africa Bacterial Vaginosis Market Overview
• 29.2. Africa Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bacterial Vaginosis Market Competitive Landscape And Company Profiles

• 30.1. Bacterial Vaginosis Market Competitive Landscape
• 30.2. Bacterial Vaginosis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Bacterial Vaginosis Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific
• 31.2. Becton Dickinson
• 31.3. Viatris Inc.
• 31.4. Otsuka Pharmaceutical
• 31.5. LabCorp
• 31.6. Quest Diagnostics
• 31.7. Organon & Co.
• 31.8. UT Southwestern Medical Center
• 31.9. Hologic Inc.
• 31.10. bioMerieux SA
• 31.11. Shionogi & Company Limited
• 31.12. Melinta Therapeutics Inc.
• 31.13. Evofem Biosciences
• 31.14. Gedea Biotech
• 31.15. Fleurstat

32. Global Bacterial Vaginosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bacterial Vaginosis Market

34. Recent Developments In The Bacterial Vaginosis Market

35. Bacterial Vaginosis Market High Potential Countries, Segments and Strategies

• 35.1 Bacterial Vaginosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bacterial Vaginosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bacterial Vaginosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료